Loading...
Basilea Pharmaceutica Community
SWX:BSLN Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 5 Fair Values set on narratives written by author
Community Investing Ideas
Emerging Markets And Drug Resistance Will Drive Global Expansion
Key Takeaways Expanding global sales of key anti-infective drugs and successful commercialization partnerships are driving top-line growth and increased royalty income. Strategic pipeline development, acquisitions, and a partnership-driven model support profit growth, regulatory momentum, and future market expansion.Read more
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
CHF 90.42
48.2% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
9.68% p.a.
Profit Margin
23.91%
Future PE
16.39x
Share price in 2028
CHF 95.69